Itch risk factors

Revision as of 01:52, 15 August 2021 by Nnabude (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Itch Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Itch from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Itch risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Itch risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Itch risk factors

CDC on Itch risk factors

Itch risk factors in the news

Blogs on Itch risk factors

Directions to Hospitals Treating Itch

Risk calculators and risk factors for Itch risk factors

Overview

Common risk factors in the development of itch are allergic reactions, cholestasis , diabetes mellitus, and drug side effect.

Risk factors


References

  1. Decock S, Roelandts R, Steenbergen WV, Laleman W, Cassiman D, Verslype C; et al. (2012). "Cholestasis-induced pruritus treated with ultraviolet B phototherapy: an observational case series study". J Hepatol. 57 (3): 637–41. doi:10.1016/j.jhep.2012.04.023. PMID 22613002.
  2. 2.0 2.1 Al Hasan M, Fitzgerald SM, Saoudian M, Krishnaswamy G (2004). "Dermatology for the practicing allergist: Tinea pedis and its complications". Clin Mol Allergy. 2 (1): 5. doi:10.1186/1476-7961-2-5. PMC 419368. PMID 15050029.
  3. Neilly JB, Martin A, Simpson N, MacCuish AC (1986). "Pruritus in diabetes mellitus: investigation of prevalence and correlation with diabetes control". Diabetes Care. 9 (3): 273–5. doi:10.2337/diacare.9.3.273. PMID 3731993.
  4. Polat M, Oztas P, Ilhan MN, Yalçin B, Alli N (2008). "Generalized pruritus: a prospective study concerning etiology". Am J Clin Dermatol. 9 (1): 39–44. doi:10.2165/00128071-200809010-00004. PMID 18092842.
  5. Gonçalves F (2010). "Thalidomide for the control of severe paraneoplastic pruritus associated with Hodgkin's disease". Am J Hosp Palliat Care. 27 (7): 486–7. doi:10.1177/1049909110362523. PMID 20231735.
  6. Kantor GR, Lookingbill DP (1983). "Generalized pruritus and systemic disease". J Am Acad Dermatol. 9 (3): 375–82. doi:10.1016/s0190-9622(83)70144-1. PMID 6630598.
  7. Stäubli M (1981). "[Pruritus--a little known iron-deficiency symptom]". Schweiz Med Wochenschr. 111 (38): 1394–8. PMID 7280639.
  8. Mullin GE, Eastern JS (1986). "Cutaneous signs of thyroid disease". Am Fam Physician. 34 (4): 93–8. PMID 3766364.
  9. Narita I, Iguchi S, Omori K, Gejyo F (2008). "Uremic pruritus in chronic hemodialysis patients". J Nephrol. 21 (2): 161–5. PMID 18446709.

Template:WH Template:WS